A review on the role of different ephrins in glioma

Intranasal Delivery of Temozolomide-Conjugated Gold Nanoparticles Functionalized with Anti-EphA3 for Glioblastoma Targeting

(2021) Liangxiao Wang et al.   MOLECULAR PHARMACEUTICS

Polycomb-mediated repression of EphrinA5 promotes growth and invasion of glioblastoma

(2020) Barbara Ricci et al.   ONCOGENE

EPH receptor B2 stimulates human monocyte adhesion and migration independently of its EphrinB ligands

(2020) Dianne Vreeken et al.   JOURNAL OF LEUKOCYTE BIOLOGY

The effects of ephrinB2 signaling on proliferation and invasion in glioblastoma multiforme

(2020) Shilpa Bhatia et al.   MOLECULAR CARCINOGENESIS

CircRNA EPHB4 modulates stem properties and proliferation of gliomas via sponging miR‐637 and up‐regulating SOX10

(2020) Chen Jin et al.   Molecular Oncology

The Small Molecule Ephrin Receptor Inhibitor, GLPG1790, Reduces Renewal Capabilities of Cancer Stem Cells, Showing Anti-Tumour Efficacy on Preclinical Glioblastoma Models

(2019) Giovanni Gravina et al.   Cancers

Ligand-dependent EphB4 activation serves as an anchoring signal in glioma cells

(2019) Yosuke Kawahara et al.   CANCER LETTERS

EphB4 mediates resistance to antiangiogenic therapy in experimental glioma

(2018) Christian Uhl et al.   ANGIOGENESIS

Co-targeting ephrin receptor tyrosine kinases A2 and A3 in cancer stem cells reduces growth of recurrent glioblastoma.

(2018) Maleeha A Qazi et al.   CANCER RESEARCH

Long Noncoding RNA GMAN, Up-regulated in Gastric Cancer Tissues, Is Associated With Metastasis in Patients and Promotes Translation of Ephrin A1 by Competitively Binding GMAN-AS

(2018) Wei Zhuo et al.   GASTROENTEROLOGY

Ephrin-B3 supports glioblastoma growth by inhibiting apoptosis induced by the dependence receptor EphA4

(2017) Amélie Royet et al.   Oncotarget

Cross-talk between the Tissue Factor/coagulation factor VIIa complex and the tyrosine kinase receptor EphA2 in cancer

(2016) Oskar Eriksson et al.   BMC CANCER

EphA2 is a key effector of the MEK/ERK/RSK pathway regulating glioblastoma cell proliferation

(2016) Yuho Hamaoka et al.   CELLULAR SIGNALLING

Tenascin-C Orchestrates Glioblastoma Angiogenesis by Modulation of Pro- and Anti-angiogenic Signaling

(2016) Tristan Rupp et al.   Cell Reports

EphrinB2 drives perivascular invasion and proliferation of glioblastoma stem-like cells

(2016) Benjamin Krusche et al.   eLife

Eph Receptors and Ephrins: Therapeutic Opportunities

(2015) Antonio Barquilla et al.   Annual Review of Pharmacology and Toxicology

Effects of altered ephrin-A5 and EphA4/EphA7 expression on tumor growth in a medulloblastoma mouse model

(2015) Shilpa Bhatia et al.   Journal of Hematology & Oncology

Ephs and Ephrins in malignant gliomas

(2014) Sara Ferluga et al.   GROWTH FACTORS

The epidemiology of glioma in adults: a "state of the science" review

(2014) Q. T. Ostrom et al.   NEURO-ONCOLOGY

EphA2 promotes infiltrative invasion of glioma stem cells in vivo through cross-talk with Akt and regulates stem cell properties

(2014) H Miao et al.   ONCOGENE

The EphA2 Receptor Drives Self-Renewal and Tumorigenicity in Stem-like Tumor-Propagating Cells from Human Glioblastomas

(2012) Elena Binda et al.   CANCER CELL

EphB2 activity plays a pivotal role in pediatric medulloblastoma cell adhesion and invasion

(2012) Arend H. Sikkema et al.   NEURO-ONCOLOGY

Role of Eph/ephrin tyrosine kinase in malignant glioma

(2011) M. Nakada et al.   NEURO-ONCOLOGY

Ephrin-B2 regulates VEGFR2 function in developmental and tumour angiogenesis

(2010) Suphansa Sawamiphak et al.   NATURE

Up-regulation of EphA2 and down-regulation of EphrinA1 are associated with the aggressive phenotype and poor prognosis of malignant glioma

(2010) Xia Li et al.   TUMOR BIOLOGY

EphA2 Mediates Ligand-Dependent Inhibition and Ligand-Independent Promotion of Cell Migration and Invasion via a Reciprocal Regulatory Loop with Akt

(2009) Hui Miao et al.   CANCER CELL

EphrinA5 acts as a tumor suppressor in glioma by negative regulation of epidermal growth factor receptor

(2009) J-J Li et al.   ONCOGENE

EphA4 promotes cell proliferation and migration through a novel EphA4-FGFR1 signaling pathway in the human glioma U251 cell line

(2008) J. Fukai et al.   MOLECULAR CANCER THERAPEUTICS

Soluble monomeric EphrinA1 is released from tumor cells and is a functional ligand for the EphA2 receptor

(2008) J Wykosky et al.   ONCOGENE